Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
M.D. Anderson Cancer Center
Massachusetts General Hospital
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
University of California, San Diego
M.D. Anderson Cancer Center
Medical College of Wisconsin
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Gruppo Italiano Malattie EMatologiche dell'Adulto
M.D. Anderson Cancer Center
Milton S. Hershey Medical Center
Masonic Cancer Center, University of Minnesota
University of Michigan Rogel Cancer Center
Oncology Specialists, S.C.
SWOG Cancer Research Network
Massachusetts General Hospital
Wake Forest University Health Sciences
Children's Oncology Group
Massachusetts General Hospital
St. Jude Children's Research Hospital
SWOG Cancer Research Network
Sanofi
M.D. Anderson Cancer Center